News

Analyst: Clinical News, Catalysts Portend ‘Rich’ Q2/21 for Biopharma

May 27, 2021 (Investorideas.com Newswire) Second-quarter clinical events related to Anavex Life Sciences’ pipeline are summarized in a Dawson James Securities report.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:News